Cargando…
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
Uveal melanoma (UM) is the most frequent primary ocular cancer in adults, accounting for 5% of all melanomas. Despite effective treatments for the primary tumour, up to 50% of UM patients will develop metastasis, leading to a very poor prognosis and a median overall survival of 6 to 12 months, with...
Autores principales: | Piperno-Neumann, Sophie, Piulats, Jose Maria, Goebeler, Matthias, Galloway, Iain, Lugowska, Iwona, Becker, Jürgen C., Vihinen, Pia, Van Calster, Joachim, Hadjistilianou, Theodora, Proença, Rui, Caminal, Jose Maria, Rogasik, Muriel, Blay, Jean-Yves, Kapiteijn, Ellen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628377/ https://www.ncbi.nlm.nih.gov/pubmed/31200439 http://dx.doi.org/10.3390/cancers11060817 |
Ejemplares similares
-
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019) -
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020
por: Rodrigues, Manuel, et al.
Publicado: (2019) -
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma
por: Bauer, Sebastian, et al.
Publicado: (2023) -
Upcoming translational challenges for uveal melanoma
por: Nabil, Amirouchene-Angelozzi, et al.
Publicado: (2015) -
Upcoming translational challenges for uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2015)